Tallon Kerry Patrick Invests $169,000 in Quanterix Co. (NASDAQ:QTRX)

Tallon Kerry Patrick acquired a new position in Quanterix Co. (NASDAQ:QTRX) in the fourth quarter, Holdings Channel.com reports. The firm acquired 15,710 shares of the company’s stock, valued at approximately $169,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Portolan Capital Management LLC boosted its holdings in shares of Quanterix by 31.4% in the 3rd quarter. Portolan Capital Management LLC now owns 2,520,686 shares of the company’s stock worth $32,668,000 after purchasing an additional 602,656 shares in the last quarter. Easterly Investment Partners LLC boosted its holdings in shares of Quanterix by 26.5% in the 3rd quarter. Easterly Investment Partners LLC now owns 876,133 shares of the company’s stock worth $11,355,000 after purchasing an additional 183,387 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Quanterix by 2.2% during the 3rd quarter. Geode Capital Management LLC now owns 858,667 shares of the company’s stock valued at $11,131,000 after acquiring an additional 18,231 shares during the period. State Street Corp boosted its holdings in Quanterix by 2.2% during the 3rd quarter. State Street Corp now owns 836,443 shares of the company’s stock valued at $10,840,000 after acquiring an additional 18,050 shares during the period. Finally, Emerald Advisers LLC boosted its holdings in Quanterix by 5.6% during the 3rd quarter. Emerald Advisers LLC now owns 719,217 shares of the company’s stock valued at $9,321,000 after acquiring an additional 38,230 shares during the period. 86.48% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, TD Cowen increased their target price on Quanterix from $13.50 to $16.00 and gave the company a “hold” rating in a report on Wednesday, November 13th.

Quanterix Stock Performance

Shares of QTRX stock opened at $8.82 on Friday. Quanterix Co. has a 1-year low of $8.21 and a 1-year high of $29.70. The business has a 50-day moving average of $11.43 and a 200 day moving average of $12.55.

About Quanterix

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.